Categories: world

Gilead Sciences to donate HIV Prevention Drug Truvada to the United States, with “Mixed” Reaction

(newser) –On Thursday, President tweeted a news: Announcement by Secretary of Health and Human Services Alex Azar that Gilead Sciences, manufacturer of the only approved HIV prevention drug, would donate enough Truvada to treat 200 000 patients each year through at least 2025, and possibly 2030. Azar noted the initiative would provide the once-daily pill-a treatment called pre-exposure prophylaxis or PrEP to uninsured people at risk for HIV, especially in "priority" areas ". The cost of one year's value of Truvada is about $ 20,000 in the United States. "Ensuring this commitment is an important step in the Trump administration's efforts to use the prevention and treatment tools we need to end the HIV epidemic in America in 2030," said Azar, by New York Times . and Stat News, however, notes "mixed" reaction. "This is a very significant development that will contribute far to preventing HIV," says the AIDS institute's Carl Schmid, also co-chairman of the council's council on HIV / AIDS. But HIV activists say the Gilead donation will serve only 20% of the people who need it, and that it significantly reduces the price of Truvada and its possible compensation, Descovy would help more people across the board. Gilead has also brought proceedings against companies trying to offer cheaper generic versions of Truvada in the United States, all with secret settlements. "Let's call a spade a spade," an infectious disease doctor at the Massachusetts General Hospital tells Times . "The real cost of Truvada is about $ 60…


(newser)

On Thursday, President tweeted a news: Announcement by Secretary of Health and Human Services Alex Azar that Gilead Sciences, manufacturer of the only approved HIV prevention drug, would donate enough Truvada to treat 200 000 patients each year through at least 2025, and possibly 2030. Azar noted the initiative would provide the once-daily pill-a treatment called pre-exposure prophylaxis or PrEP to uninsured people at risk for HIV, especially in “priority” areas “. The cost of one year’s value of Truvada is about $ 20,000 in the United States. “Ensuring this commitment is an important step in the Trump administration’s efforts to use the prevention and treatment tools we need to end the HIV epidemic in America in 2030,” said Azar, by New York Times . and Stat News, however, notes “mixed” reaction.

“This is a very significant development that will contribute far to preventing HIV,” says the AIDS institute’s Carl Schmid, also co-chairman of the council’s council on HIV / AIDS. But HIV activists say the Gilead donation will serve only 20% of the people who need it, and that it significantly reduces the price of Truvada and its possible compensation, Descovy would help more people across the board. Gilead has also brought proceedings against companies trying to offer cheaper generic versions of Truvada in the United States, all with secret settlements. “Let’s call a spade a spade,” an infectious disease doctor at the Massachusetts General Hospital tells Times . “The real cost of Truvada is about $ 60 a year. If you really wanted to cover everyone, you would lower the price to everyone.” (Read more about HIV stories.)

was FBAPI = & # 39; 119343999649 & # 39; ;

window.fbAsyncInit = function () { FB.init ({ AppId: FBAPI, status: true, cookie: true, xfbml: true, oauth: true authResponse: true, version: & # 39; v2.5 & # 39; });

FB.Event.subscribe (& # 39; edge.create & # 39 ;, function (answer) { AnalyticsCustomEvent (& # 39; Facebook & # 39 ;, & # 39; Like & # 39 ;, & # 39; P & # 39;); }); };

// Download SDK asynchronously (function (d, s, id) { var js, fjs = d.getElementsByTagName (s) [0]; if (d.getElementById (id)) returns; js = d.createElement (s); js.id = id; js.src = “http://connect.facebook.net/en_US/sdk.js”; fjs.parentNode.insertBefore (js, fjs); } (document, “script”, “facebook-jssdk”));


Source link

Share
Published by
Faela